Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoint receptors, bi-specific antibodies, small molecules, or cellular therapies such as chimeric antigen receptor T-cells (CAR-T).
This report contains market size and forecasts of Immuno Oncology Assays in Global, including the following market information:
Global Immuno Oncology Assays Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Immuno Oncology Assays market was valued at 4567.9 million in 2021 and is projected to reach US$ 9171.1 million by 2028, at a CAGR of 10.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immunoassay Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Immuno Oncology Assays include Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies and Illumina, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immuno Oncology Assays companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immuno Oncology Assays Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Immuno Oncology Assays Market Segment Percentages, by Type, 2021 (%)
Immunoassay
Flow Cytometry
PCR
Next Generation Sequencing
Global Immuno Oncology Assays Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Immuno Oncology Assays Market Segment Percentages, by Application, 2021 (%)
Research
Clinical Diagnostics
Global Immuno Oncology Assays Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Immuno Oncology Assays Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immuno Oncology Assays revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Immuno Oncology Assays revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fischer Scientific
Roche Diagnostics
Agilent Technologies
Illumina